ArticleBreast cancer research : BCR2024

Identification of CD160-TM as a tumor target on triple negative breast cancers: possible therapeutic applications.

Claire Scheffges et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.